|
Market Closed -
NYSE
04:00:03 2026-10-26 pm EDT
|
5-day change | 1st Jan Change | ||
| 330.00 USD | -0.30% |
|
-2.94% | -2.29% |
| Oct. 21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| Oct. 21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 62.97B 56.31B 52.1B 47.17B 88.28B 5,991B 89.73B 627B 248B 3,134B 236B 231B 9,922B | P/E 2026 * |
18.1x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 70.41B 62.96B 58.25B 52.74B 98.71B 6,699B 100B 701B 277B 3,504B 264B 259B 11,094B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.2x |
| Free-Float |
61.21% | Yield 2026 * |
0.72% | Yield 2027 * | 0.74% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Xetra
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | -0.30% | ||
| 1 week | -2.94% | ||
| Current month | +9.91% | ||
| 1 month | +7.52% | ||
| 3 months | +6.49% | ||
| 6 months | +7.08% | ||
| Current year | -2.29% |
| 1 week | 329.17 |  | 344.44 |
| 1 month | 295.01 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 182.75 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Other | Director | 275 | 0.0001% | ||
| 10/1/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 10/1/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | -2.94% | -0.81% | +74.97% | 63.16B | |
| +1.14% | +0.79% | -17.32% | +11.60% | 179B | |
| -0.33% | +2.75% | -19.82% | +18.39% | 118B | |
| -0.65% | +2.18% | +1.20% | +34.70% | 117B | |
| -3.42% | +15.09% | -44.16% | +5.61% | 93.26B | |
| +1.47% | +1.73% | +8.61% | +82.41% | 55.68B | |
| -1.27% | +2.96% | +5.68% | -22.74% | 54.18B | |
| +1.75% | +2.59% | -11.02% | +43.47% | 44.15B | |
| +0.03% | +6.23% | -5.17% | -7.53% | 33.95B | |
| -1.17% | -4.26% | - | - | 29.91B | |
| Average | -0.30% | +2.55% | -9.20% | +26.77% | 78.83B | |
| Weighted average by Cap. | -0.26% | +3.11% | -12.33% | +24.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 301B 279B 252B 472B 32,065B 480B 3,355B 1,327B 16,771B 1,265B 1,238B 53,102B | 352B 314B 291B 263B 493B 33,459B 501B 3,501B 1,385B 17,500B 1,320B 1,292B 55,411B |
| Net income | 3.58B 3.2B 2.96B 2.68B 5.02B 341B 5.1B 35.64B 14.1B 178B 13.44B 13.15B 564B | 2.84B 2.54B 2.35B 2.13B 3.99B 271B 4.05B 28.32B 11.2B 142B 10.68B 10.45B 448B |
| Net Debt | 7.44B 6.65B 6.15B 5.57B 10.43B 708B 10.6B 74.04B 29.29B 370B 27.91B 27.32B 1,172B | 5.95B 5.32B 4.92B 4.45B 8.34B 566B 8.47B 59.19B 23.42B 296B 22.32B 21.84B 937B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | $330.00 | -0.30% | 993,474 |
| 26-10-23 | $331.00 | -2.21% | 1,168,293 |
| 26-10-22 | $338.48 | -0.57% | 1,183,276 |
| 26-10-21 | $340.43 | -0.83% | 1,514,590 |
| 26-10-20 | $343.27 | +0.96% | 916,877 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
